New Delhi, Sep 29 (UNI) The Pune-based Serum Institute of India (SII) said on Tuesday that it will prepare 200 million doses of Covid-19 vaccine instead of 100 million for India and other low and middle income countries of the world. The SII said it has received $300 million in funds from the Bill & Melinda Gates Foundation and Gavi Vaccine Alliance to produce 200 million doses of the vaccine by next year. SII was first funded with $ 150 million, which has now been increased to $ 300 million. Under the agreement entered into with the Bill & Melinda Gates Foundation and Gavi Vaccine Alliance, the Covid vaccine made by SII cannot be priced more than three dollars a vaccine.
The SII will make 200 million doses of the vaccine developed by Oxford University and pharmaceutical company AstraZeneca and Novona’s Corona vaccine by next year under this agreement.
The vaccine prepared by SII will be distributed among India and other low and middle income countries of the world.
